A history-based risk stratification of cephalosporin allergy labels appeared feasible when using the validated criteria for penicillin allergy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
“The field of allergy has known for a while now that most patients who report cephalosporin allergies are unlikely to test positive,” Cosby A. Stone Jr., MD, MPH, assistant professor in allergy/immunology with Vanderbilt University Medical Center Drug Allergy Research, told Healio.
Previously, Stone and colleagues found that only approximately 8%